Concretely: fibrillation · ecnoglutide · Medutest.
I want a method I can write down and repeat, not a rule of thumb.
I would rather over-engineer this than discover a problem later, within reason.
Which parts of this are load-bearing and which parts are habit?
The relevant principle is that anything you find before reconstitution is the supplier's, and anything you find after might be yours.
Look for fibres, glass fragments and dark particulate in the cake. Glass is the one that matters and is usually a crimping or handling artefact rather than a synthesis one.
| Configuration | Dead volume | Loss at 5 mg/mL | Over 20 draws |
|---|---|---|---|
| Fixed-needle insulin syringe | 3–5 µL | 15–25 µg | 0.3–0.5 mg |
| Low-dead-space, detachable | <2 µL | <10 µg | <0.2 mg |
| Standard luer-lock + 30G | 35–60 µL | 175–300 µg | 3.5–6 mg |
| Luer-lock + 21G drawing needle | 70–100 µL | 350–500 µg | 7–10 mg |
Confirm the lot code is physically on the vial and legible, and that it matches the certificate and the invoice. A code on the box only ties a certificate to a box.
Visual inspection for particulate matter is a pharmacopoeial requirement for parenteral products and the standard technique uses both light and dark backgrounds.
Inspect before reconstitution. Afterwards you cannot tell whose particle it is.
edited 31 Mar 2026 by kofi_mensah — reworded for clarity after a comment
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemAnswering this needs to know what you are looking for, because most people inspect vials without a list and therefore see nothing.
Check the aluminium crimp is fully seated with no lift at the edge, the flip-off cap has not been previously removed, and the stopper sits flush without a visible gap or dimple.
Specifically, melt-back at the stopper — a glassy ring where the cake meets the closure — indicates the cycle ran warm at the top of the vial. Cosmetic in most cases, informative always.
A vial that passes inspection has passed a very weak test. It has not been verified.
The lot code has to be on the vial. A code on the box ties nothing to anything.
The short version: intact crimp, seated stopper, legible lot code, and a cake that looks like a cake.
Inspect the powder against both a white and a black background under good light. Discolouration, browning or a yellow tinge on a peptide that should be white is worth photographing before doing anything else.
Weigh the vial if you have a scale reading to a milligram. It will not give you content, but a vial several tens of milligrams lighter than its siblings is a fill problem.
Melt-back and collapse are documented lyophilisation cycle defects with well-described visual appearances.
Photograph anything unexpected before touching it further.
The lot code on the vial, not on the box, is what ties your material to a certificate.
Check the fill looks proportionate to the label claim. Ten milligrams of peptide is a small volume of powder, but it is not nothing, and a vial that looks empty is worth a photograph.
Lot traceability to the primary container rather than to secondary packaging is a basic requirement of any documentation system worth the name.
Crimp, stopper, label, contents. Light background and dark background.
Answer first: inspect before you reconstitute, because after reconstitution you cannot distinguish a particle that arrived with the powder from one you introduced.
After reconstitution, hold against a light and look for haze, floaters or a Tyndall effect. A clear solution that goes clear on contact is what a well-made preparation looks like.
Container closure integrity depends on the crimp and stopper seating, which is why those are the first things checked in any incoming-goods inspection.
Nothing here is medical advice, and research-use compounds are not approved for human use.
Passing inspection is a weak result. It rules out the obvious and nothing else.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.